Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-06-07
1998-04-21
Lambkin, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
564 36, A61K 31175, C07C28114
Patent
active
057418187
ABSTRACT:
A compound of general formula I below useful as an anticonvulsant for disorders of the central nervous system: ##STR1## wherein: R.sup.1, R.sup.2, R.sup.3 and R.sup.4 may be the same or different and each represents a hydrogen or halogen atom, or a C.sub.1-9 alkyl, C.sub.3-9 cycloalkyl, cyano, C.sub.1-9 alkoxy or C.sub.6-10 aryloxy group; R.sup.5 represents a hydrogen atom or a C.sub.1-9 alkyl, C.sub.3-9 cycloalkyl or C.sub.6-10 aryl group; and X is oxygen or sulfur; or a pharmaceutically-acceptable salt thereof. The compound may be adimistered orally for treating convulsions in humans or animals.
REFERENCES:
patent: 3139458 (1964-06-01), Paquette
patent: 3300484 (1967-01-01), Pappo
patent: 3303214 (1967-02-01), Anderson et al.
patent: 3304323 (1967-02-01), Fonken et al.
patent: 3392171 (1968-07-01), Fonken et al.
patent: 3558654 (1971-01-01), Bamford et al.
patent: 3712914 (1973-01-01), Tilles
patent: 4015011 (1977-03-01), Schromm et al.
patent: 4394514 (1983-07-01), Kruse
patent: 4454337 (1984-06-01), Kruse
Chemical Abstract 50 4836 (1956).
Genzo Ito: Diesen Bulletin, 5 397 (1957)*.
Dimmock et al (I)., J. Med. Chem. 1993 36, pp. 2243-2252.
Krall et al "Antiepileptic drug development: II Anti-convulsant drug screening"-Epilepsia 1978, 19 409-428.
Yeager et al: Synthesis, 1991, pp. 63-68.
Racine: Electroencephalogr. Clin. Neurophysiol., 1972, 32, 281-294.
Skeen et al: Soc. Neurosci., 1990, 16(1) 307.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014745 see BRN 254223 & J. Org. Chem., vol. 26, 1961, pp. 2353-2355.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014746 see BRN 1890700, 3400167, 3400193, 3410343, 3419487, 341220, 3436628 & Bull. Soc. Chim. Fr., 1954. pp. 644, 646.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014747 see BRN 3396690 & Yakugaku Zasshi, vol. 72, 1952, p. 300.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014748 see BRN 3389800 & J. Chem. Soc., 1942, p. 347, 353.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014749 & J. Amer. Chem. Soc., vol. 65, 1943, p. 1736, 1738.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014750 see BRN 3422330, 3449771 & Yakugaku Zasshi, vol. 73, 1953, p. 243.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP 02014751 see BRN 3382967 & J. Amer. Chem. Soc., vol. 58, 1936, p. 1808, 1810.
Database Crossfire. Beilstein Informationsgesellschaft GmbH. XP002014752 see BRN 3347507 & Yakugaku Zasshi, vol. 57, 1937, p. 36, 37.
European Journal of Medicinal Chemistrychimica Therapeutica., vol. 26, No. 5, 1991, Paris Fr, pp. 529-534, XP002014742, J.R. Dimmock et al.: "Evaluation of the thiosemicarbazones of some aryl alkyl ketones and related compounds for anticonvulsant activities" cited in the application, see whole document; especially scheme 1, compound 1n; p. 531, table I. (II).
Pharmazie, vol. 46, No. 7, 1991, Berlin De, pp. 538-539, XP002014743 J.R. Dimmock et al.: "Evaluation of some mannich bases of 1-aryl-1-ethanones and related ketones for anticonvulsant activities" p. 539, copound 2f. (III).
Eur J. Med. Chem. (1995), 30(4), 287-301, XP002014744, Dimmock, J.R. et al: "Some aryl semicarbazones possessing anticonvulsant activities." IV.
Synthesis, No. 1, 1991, Stuttgart De, pp. 63-68, XP002014786 G.W. Yeager et al.: "A convient method for the preparation of 4-aryloxyphenols." p. 65, right-hand column, line 8 -line 24.
Lambkin Deborah
University of Saskatchewan
LandOfFree
Semicarbazones having CNS activity and pharmaceutical preparatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Semicarbazones having CNS activity and pharmaceutical preparatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Semicarbazones having CNS activity and pharmaceutical preparatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057884